This useful resource brings together both venture capital and private equity investors involved in pharmaceuticals, biotechnology and medical devices. This edition has been extensively updated, offering valuable, current, and detailed information to individuals, entrepreneurs, and businesses worldwide. The new edition is the most current, comprehensive picture of this dynamic industry to date. All company profiles include specific data that creates a detailed picture of the firm and its investment parameters. This database offers direct access to over 500 firms and thousands of partners with detailed contact information and extensive data on investment and funds.
The Directory provided accurate information on:
- Firm Name, Address, Phone & Fax Numbers
- Managing Partners with their Degrees, Directorships & Professional Background
- Satellite Offices
- E-Mail and Website Addresses
- Mission Statement
- Average & Minimum Investments
- Fund Size
- Investment Criteria/Stage Preferences
- Industry Preferences & Geographic Preferences
- Portfolio Companies
- Other Locations
Categories of industries included in this Directory are:
- Bulk Pharmaceuticals
- Drug Development
- Drug Delivery
- OTC/Healthcare Products
- Clinical Research
- Research & Development
- Life Sciences
- Medical Technology
This Directory will enable you to:
- Find Firms that are specifically interested in their industry group.
- Search for Firms that match the investment level they need. From $200,000 to $50 million, you’ll be able to generate a list to match your requirements.
- Find which Venture Capital Firms have funded specific companies.
The companies are arranged alphabetically by name with multiple offices of the same firm listed alphabetically by city. Indexes include Company Names; Industry Preference; Executives; and Geographical. Covering all of Europe, the Americas, Asia, the Middle East and Africa the data in this Directory is also available in Book, PDF or CD-Rom formats. We are confident that this new edition offers a valuable resource to those needing to research the pharmaceutical investment community worldwide.
Table of Contents
- Content Page
- In-depth profiles